Cost & insurance review · Updated July 2026
How much does compounded semaglutide cost?
Medically reviewed by Editorial Medical Review, MD, NAMS-CMP
Quick answer
$150-$400/mo. Compounded semaglutide pricing ranges $150-$400/month in 2026 where legally available. Availability narrowed substantially after the FDA declared the semaglutide and tirzepatide shortages resolved in late 2024. Compounded GLP-1 drugs are not FDA-approved, not insurance-covered, and carry quality-control variance — verify pharmacy licensure and current legal status before purchase.
Price ranges by tier
What each pricing tier includes, sourced from manufacturer pricing pages, Cost Plus Drugs, KFF, LillyDirect, and NovoCare.
Compounded semaglutide (503A pharmacy, cash)
$150-$400/mo- Cash-pay only
- Non-standard vial concentrations (2.5-5 mg/mL common)
- Often includes vitamin B12 or glycine additives
Telehealth compounded prescription (bundled)
$199-$499/mo- Includes async clinician consult
- Ships direct to patient
- Quality control varies by platform
FDA-approved NovoCare Self Pay (Wegovy)
$499/mo- Cash-pay direct manufacturer program
- FDA-approved auto-injector pens
- Full safety/efficacy data
FDA-approved LillyDirect Self Pay (Zepbound vials)
$349-$599/mo- Cash-pay direct manufacturer program
- Manual-draw vials
- FDA-approved product
Factors that affect cost
- Pharmacy licensure status (503A vs 503B)
- Vial concentration and volume
- Whether telehealth platform bundles consult + medication
- State (some state boards restrict compounding tighter than FDA)
- Post-2024 legal-status uncertainty pushes prices variable
Insurance context
US commercial and government insurance plans do not cover compounded GLP-1 drugs. Only FDA-approved versions (Ozempic, Wegovy, Mounjaro, Zepbound) are insurance-coverable. Compounded semaglutide remains cash-pay only, and availability has narrowed sharply since the FDAs late-2024 shortage resolution.
Financial help options
- FDA-approved cash-pay programs: NovoCare Self Pay ($499/mo) and LillyDirect Self Pay ($349-$599/mo) are safer FDA-approved alternatives at comparable cash prices.
- HSA/FSA accounts: Compounded GLP-1 is HSA/FSA-eligible with a valid prescription and letter of medical necessity from a licensed clinician.
- Verify pharmacy status ↗: Check FDA warning letters and state board of pharmacy licensure before ordering compounded product.
Related brands
Editorial cross-links only — no affiliate CTAs. Follow each link for our full brand review, formulary, and clinician model.
Related questions
Frequently asked questions
- Is compounded semaglutide safe?
- Safety depends on the compounding pharmacy. FDA has received multiple adverse-event reports tied to compounded GLP-1 — primarily dosing errors due to non-standard vial concentrations and confusion between mg and units. Verify pharmacy is 503A or 503B registered.
- Why is compounded GLP-1 cheaper than FDA-approved?
- Compounding pharmacies skip FDA approval and do not pay branded drug premiums. Cash-pay only ($150-$400/month) vs $935-$1,349/month list for FDA-approved versions. Price gap reflects regulatory, marketing, and quality-control differences.
- Will compounded GLP-1 still be available in 2026?
- Availability is narrowing. After FDA declared semaglutide and tirzepatide shortages resolved in late 2024, legal grounds for compounded production substantially contracted. Some 503B facilities continue for specific clinical scenarios only.
- Can insurance cover compounded GLP-1?
- No. US commercial and government insurance plans do not cover compounded GLP-1 drugs. Only FDA-approved versions are insurance-coverable. Compounded remains cash-pay only.
Sources
Every pricing figure is sourced from public manufacturer pages, Cost Plus Drugs, KFF, or FDA data. External links open in a new tab.
Related cost questions
ClearHormones publishes editorial pricing research quarterly. Pricing may change without notice — always confirm current terms on the manufacturer or brand pricing page before purchasing.